Bank of Montreal
CSTL icon

Bank of Montreal’s Castle Biosciences CSTL Stock Holding History

Bank of Montreal’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44,818
Closed -$3.3M – 3555
2021
Q3 		$3.3M Sell
44,818
-1,700
-4% -$120K ﹤0.01% 1833
2021
Q2 		$3.51M Buy
46,518
+420
+0.9% +$27.7K ﹤0.01% 1780
2021
Q1 		$3.26M Sell
46,098
-20,960
-31% -$1.58M ﹤0.01% 1550
2020
Q4 		$5.13M Sell
67,058
-82,541
-55% -$4.47M ﹤0.01% 1371
2020
Q3 		$7.96M Buy
149,599
+62,837
+72% +$2.8M 0.01% 961
2020
Q2 		$3.8M Buy
+86,762
New +$2.96M ﹤0.01% 1309
2020
Q1 		– Sell
-484
Closed -$17K – 4203
2019
Q4 		$17K Buy
+484
New +$11.8K ﹤0.01% 4382

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bank of Montreal's CSTL Position: Q4 2021 in Review

Bank of Montreal sold out of Castle Biosciences (CSTL) in Q4 2021, closing a stake of 44,818 shares — an estimated $3.3M sold.

Bank of Montreal first reported a position in CSTL in Q4 2019 and held it in 7 quarters. The position peaked at $7.96M in Q3 2020. 159 funds tracked by Wall St. Rank hold CSTL as of Q4 2021.

  • Bank of Montreal reported no remaining Castle Biosciences position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 44,818 Castle Biosciences shares in Q4 2021, an estimated $3.3M.
  • Bank of Montreal first reported a position in Castle Biosciences in Q4 2019 and held it in 7 quarters.
  • Bank of Montreal's Castle Biosciences position peaked at $7.96M in Q3 2020.
  • 159 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.